No mandatory relabelling of drugs after GST cut: Pharma pricing body

Tribune News Service

New Delhi, Updated At : 02:03 AM Sep 17, 2025 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has clarified that drug manufacturers need not recall medicines already released in the market before September 22, the implementation date for new GST rates.

NPPA has clarified that medicines and medical devices already in the supply chain before September 22 will not require relabelling.

It has stated that recalling, re-stickering, or re-labelling packs already released into the market is not mandatory.

The move comes after the GST council-led by Finance Minister Nirmala Sitharaman announced to cut GST on drugs and devices to 5 per cent from 18 per cent.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles